The new face of HIV in Florida

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

FDA approves once-daily Idvynso tablet for treating HIV

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...

page 5 from 20